Raiders deal Maxx Crosby to Ravens: Trade details

Raiders deal Maxx Crosby to Ravens: Trade details

Apparently what happens in Vegas doesn’t stay in Vegas – at least when it comes to Maxx Crosby. The Las Vegas Raiders agreed to trade Crosby to the Baltimore Ravens, per multiple reports. Vegas will acquire 2026 and 2027 first-round NFL draft picks from Baltimore in exchange for the star pass-rusher, ESPN reports. The deal […]

Read More
 Must-see home run celebration electrifies World Baseball Classic

Must-see home run celebration electrifies World Baseball Classic

Vladimir Guerrero Jr. brought the jacket. Junior Caminero supplied the trot. And collectively, the Dominican Republic served notice it will be an irrepressible, sartorially smashing presence in the World Baseball Classic. Given an early scare by Dusty Baker’s heavy underdog Nicaragua squad, the Dominicans charged up loanDepot Park in Miami when Caminero put a charge […]

Read More
 Nuvau Minerals Announces Closing of Final Tranche of Brokered Private Placement

Nuvau Minerals Announces Closing of Final Tranche of Brokered Private Placement

Nuvau Minerals Inc. (TSXV: NMC,OTC:NMCPF) (the ‘Company’ or ‘Nuvau’) is pleased to announce that it has closed the second and final tranche of its previously announced brokered private placement pursuant to which the Company issued (i) an aggregate of 7,928,523 common shares of the Company (each, a ‘FT Share’) that qualify as ‘flow-through shares’ within […]

Read More
 Venezuela Gold Set for US Market in Brokered Deal

Venezuela Gold Set for US Market in Brokered Deal

A new US-Venezuela gold deal could soon channel hundreds of kilograms of bullion from the South American nation into American refineries. Venezuela’s state-owned mining company, Minerven, has agreed to sell between 650 and 1,000 kilograms of gold dore bars to commodities trading house Trafigura under a multimillion-dollar arrangement brokered with the involvement of US officials, […]

Read More
 InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of disease-modifying small molecule drug candidates that target CB1CB2 receptors, today announced an update regarding BayMedica LLC (‘BayMedica’), a wholly owned subsidiary of the Company, in light of ongoing uncertainty surrounding U.S. federal legislation. As previously announced, H.R. […]

Read More